The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line

Background: Colorectal cancer becomes one of the most common cancer in Indonesia. Fluorouracil is an essential drug in colorectal cancer therapy as it has been supplemented in about 69% of current regiments of chemotherapy. However, drug resistance has reduced its clinical applications. Many factors...

Full description

Bibliographic Details
Main Authors: Yolanda Dyah Kartika, Indwiani Astuti, Woro Rukmi Pratiwi
Format: Article
Language:English
Published: Faculty of Medicine 2016-04-01
Series:JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
Subjects:
Online Access:https://journal.uii.ac.id/JKKI/article/view/4503
id doaj-c72de6e97d8844aa914edd97d77cb7a0
record_format Article
spelling doaj-c72de6e97d8844aa914edd97d77cb7a02020-11-24T22:22:41ZengFaculty of MedicineJKKI (Jurnal Kedokteran dan Kesehatan Indonesia)2085-41452527-29502016-04-0172596410.20885/JKKI.Vol7.Iss2.art54048The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell lineYolanda Dyah Kartika0Indwiani Astuti1Woro Rukmi Pratiwi2Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah MadaDepartment of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah MadaDepartment of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah MadaBackground: Colorectal cancer becomes one of the most common cancer in Indonesia. Fluorouracil is an essential drug in colorectal cancer therapy as it has been supplemented in about 69% of current regiments of chemotherapy. However, drug resistance has reduced its clinical applications. Many factors that contribute to fluorouracil resistance have been investigated including overexpression of Multidrug Resistance Protein 5 (MRP 5) and high level expression of Thymidylate Synthase (TS). Therefore, the expression of those proteins may become key indicators to predict the presence of resistance in the model of fluorouracil-resistance-WiDr colon cancer cell line. Objective: The aim of this study is to characterize a 5-FU acquired resistance WiDr colon cancer cell line, focus on the expression of MRP5 and TS. Methods: This study was a post test controlled group design. The expression of MRP5 and TS were analyzed using immunocytochemistry method. Before protein expression analysis, 4 groups of WiDr colon cancer cell line, group 1, 2, 3, and 4 (control) were treated with 4 different concentration of fluorouracil 12.3 μM, 6.15 μM, 3.08 μM, and 0 μM respectively. Previous study showed that a significant increased level of IC50 value is observed in group induced with fluorouracil 3.08 μM (group 3). Statistical tests for protein expression performed with SPSS version 19 using Kruskall Wallis with 95% confidence level (p<0.05). Results: The expression of MRP5 and TS in the group developed fluorouracil resistance (group 3) were significantly increased compared to control group (p<0.05). In contrast, the other group exposed with higher dose of fluorouracil did not show both significant increased level of IC50 nor significant different of MRP5 and TS expression compared with the control group. Conclusion: The model of fluorouracil-acquired resistant WiDr cell line expresses Thymidilate Synthase and Multidrug Resistance Protein 5. The expressions of these proteins are in accordance with the profile of fluorouracil resistancy.https://journal.uii.ac.id/JKKI/article/view/4503Fluorouracil resistance WiDr MRP5 Thymydilate Synthase
collection DOAJ
language English
format Article
sources DOAJ
author Yolanda Dyah Kartika
Indwiani Astuti
Woro Rukmi Pratiwi
spellingShingle Yolanda Dyah Kartika
Indwiani Astuti
Woro Rukmi Pratiwi
The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
Fluorouracil resistance WiDr MRP5 Thymydilate Synthase
author_facet Yolanda Dyah Kartika
Indwiani Astuti
Woro Rukmi Pratiwi
author_sort Yolanda Dyah Kartika
title The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
title_short The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
title_full The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
title_fullStr The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
title_full_unstemmed The expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance WiDr colon cancer cell line
title_sort expression of multidrug resistance protein 5 and thymydilate synthase on fluorouracil resistance widr colon cancer cell line
publisher Faculty of Medicine
series JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
issn 2085-4145
2527-2950
publishDate 2016-04-01
description Background: Colorectal cancer becomes one of the most common cancer in Indonesia. Fluorouracil is an essential drug in colorectal cancer therapy as it has been supplemented in about 69% of current regiments of chemotherapy. However, drug resistance has reduced its clinical applications. Many factors that contribute to fluorouracil resistance have been investigated including overexpression of Multidrug Resistance Protein 5 (MRP 5) and high level expression of Thymidylate Synthase (TS). Therefore, the expression of those proteins may become key indicators to predict the presence of resistance in the model of fluorouracil-resistance-WiDr colon cancer cell line. Objective: The aim of this study is to characterize a 5-FU acquired resistance WiDr colon cancer cell line, focus on the expression of MRP5 and TS. Methods: This study was a post test controlled group design. The expression of MRP5 and TS were analyzed using immunocytochemistry method. Before protein expression analysis, 4 groups of WiDr colon cancer cell line, group 1, 2, 3, and 4 (control) were treated with 4 different concentration of fluorouracil 12.3 μM, 6.15 μM, 3.08 μM, and 0 μM respectively. Previous study showed that a significant increased level of IC50 value is observed in group induced with fluorouracil 3.08 μM (group 3). Statistical tests for protein expression performed with SPSS version 19 using Kruskall Wallis with 95% confidence level (p<0.05). Results: The expression of MRP5 and TS in the group developed fluorouracil resistance (group 3) were significantly increased compared to control group (p<0.05). In contrast, the other group exposed with higher dose of fluorouracil did not show both significant increased level of IC50 nor significant different of MRP5 and TS expression compared with the control group. Conclusion: The model of fluorouracil-acquired resistant WiDr cell line expresses Thymidilate Synthase and Multidrug Resistance Protein 5. The expressions of these proteins are in accordance with the profile of fluorouracil resistancy.
topic Fluorouracil resistance WiDr MRP5 Thymydilate Synthase
url https://journal.uii.ac.id/JKKI/article/view/4503
work_keys_str_mv AT yolandadyahkartika theexpressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
AT indwianiastuti theexpressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
AT wororukmipratiwi theexpressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
AT yolandadyahkartika expressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
AT indwianiastuti expressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
AT wororukmipratiwi expressionofmultidrugresistanceprotein5andthymydilatesynthaseonfluorouracilresistancewidrcoloncancercellline
_version_ 1725767136559759360